$CEPO Balance Sheet | Understand Stock

$CEPO

$10.79 +$0.01 (0.09%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
Current Assets:
Cash
Prepaid expenses
Receivable from related party
Total Current Assets
Cash and cash equivalents held in Trust Account
Deferred offering costs
Other assets
Total Assets
Current Liabilities:
Accrued expenses
Notes payable – related party
Note payable – related party
Payable to related party
Total Current Liabilities
Forward sale securities liability
Total Liabilities
Class A ordinary shares subject to possible redemption, 20,000,000 shares issued and outstanding at redemption value of $10.71 and $10.53 per share as of June 30, 2026 and December 31, 2025, respectively
Shareholders’ Deficit:
Ordinary shares, Value
Class A Ordinary Shares
Class B Ordinary Shares
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
Total Liabilities, Commitments and Contingencies and Shareholders’ Deficit

Comments